180 related articles for article (PubMed ID: 6606012)
21. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
22. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
23. Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies.
Müller C; Ziegler A; Muller C; Hadam M; Waller HD; Wernet P; Müller G
Immunobiology; 1985 Apr; 169(3):228-49. PubMed ID: 3873401
[TBL] [Abstract][Full Text] [Related]
24. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure.
Shaw S; DeMars R; Schlossman SF; Smith PL; Lampson LA; Nadler LM
J Exp Med; 1982 Sep; 156(3):731-43. PubMed ID: 6809881
[TBL] [Abstract][Full Text] [Related]
25. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.
Radka SF; Machamer CE; Cresswell P
Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328
[TBL] [Abstract][Full Text] [Related]
26. Mouse monoclonal antibody detects a new polymorphic Ia determinant other than HLA-DR antigen: a possible allele of DC-1.
Maeda H
Tissue Antigens; 1984 Mar; 23(3):163-70. PubMed ID: 6427972
[TBL] [Abstract][Full Text] [Related]
27. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
Shackelford DA; Strominger JL
Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
[TBL] [Abstract][Full Text] [Related]
28. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.
Giles RC; Nunez G; Hurley CK; Nunez-Roldan A; Winchester R; Stastny P; Capra JD
J Exp Med; 1983 May; 157(5):1461-70. PubMed ID: 6189938
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate.
Faille A; Turmel P; Charron DJ
Blood; 1984 Jul; 64(1):33-7. PubMed ID: 6203577
[TBL] [Abstract][Full Text] [Related]
30. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines.
Accolla RS
J Exp Med; 1984 Feb; 159(2):378-93. PubMed ID: 6420499
[TBL] [Abstract][Full Text] [Related]
32. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.
DeMars R; Chang CC; Rudersdorf RA
Hum Immunol; 1983 Oct; 8(2):123-39. PubMed ID: 6417067
[TBL] [Abstract][Full Text] [Related]
33. Separation of three class II antigens from a homozygous human B cell line.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
[TBL] [Abstract][Full Text] [Related]
34. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition.
Bontrop R; Tilanus M; Mikulski M; van Eggermond M; Termijtelen A; Giphart M
Immunogenetics; 1986; 23(6):401-5. PubMed ID: 3013763
[TBL] [Abstract][Full Text] [Related]
36. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
[TBL] [Abstract][Full Text] [Related]
37. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
Karr RW
J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of a new surface membrane antigen found predominantly on malignant B lymphocytes.
Gingrich RD; Dahle CE; Hoskins KF; Senneff MJ
Blood; 1990 Jun; 75(12):2375-87. PubMed ID: 1693529
[TBL] [Abstract][Full Text] [Related]
39. Biochemical variation of human Ia like antigens detected with monoclonal antibodies.
Cohen BB; Deane DL; Van Heyningen V; Guy K; Hutchins D; Moxley M; Steel CM
Clin Exp Immunol; 1983 Jul; 53(1):41-50. PubMed ID: 6191895
[TBL] [Abstract][Full Text] [Related]
40. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
